| X0301743 | 23价肺炎球菌多糖疫苗 | 23-valent Pneumococcal Polysaccharide Vaccine | Lyophilized | Biological Products | New Drug Application | 2004-02-16 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2005-01-21 | view |
| X0408486 | b型流感嗜血杆菌结合疫苗 | Haemophilus Influenzae Type b Conjugate Vaccine | Injection | Biological Products | New Drug Application | 2005-01-12 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2006-02-10 | view |
| CYSB2101145 | 人免疫球蛋白 | human immunoglobulin | Injection | Biological Products | Supplementary Application | 2021-08-10 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2101144 | 人免疫球蛋白 | human immunoglobulin | Injection | Biological Products | Supplementary Application | 2021-08-10 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB1900268 | 人免疫球蛋白 | human immunoglobulin | Injection | Biological Products | Supplementary Application | 2019-07-24 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2019-09-26 | view |
| CYSB1900269 | 人免疫球蛋白 | human immunoglobulin | Injection | Biological Products | Supplementary Application | 2019-07-24 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2019-09-26 | view |
| CXSL2400072 | 人凝血因子IX | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(3.4) | New Drug Application | 2024-01-31 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB1100430 | 人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2011-10-14 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2012-07-03 | view |
| CYSB1200194 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2012-08-01 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2014-03-04 | view |
| CYSB2400160 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-06-21 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSS1600011 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(15) | New Drug Application | 2017-02-22 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2018-05-24 | view |
| CYSB2200014 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-01-14 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSS1900039 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(15) | New Drug Application | 2019-11-08 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2021-09-08 | view |
| CXSS1900037 | 人凝血酶原复合物 | human prothrombin complex | Lyophilized | Biological Products(15) | New Drug Application | 2019-10-24 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2020-12-23 | view |
| CXSL1400116 | 人凝血酶原复合物 | human prothrombin complex | Lyophilized | Biological Products(15) | New Drug Application | 2015-02-03 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | Certificate Issued | 2016-05-04 | view |
| CYSB2101132 | 人凝血酶原复合物 | human prothrombin complex | Lyophilized | Biological Products | Supplementary Application | 2021-07-29 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL1700171 | 人纤维蛋白原 | Human fibrinogen | Lyophilized | Biological Products(15) | New Drug Application | 2018-03-08 | 成都蓉生药业有限责任公司 | Chengdu Rongsheng Pharmaceuticals Co Ltd | In Review | 2018-10-23 | view |
| CYSB2200078 | 人纤维蛋白原 | Human fibrinogen | Lyophilized | Biological Products | Supplementary Application | 2022-03-16 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2400279 | 人纤维蛋白原 | Human fibrinogen | Lyophilized | Biological Products | Supplementary Application | 2024-10-23 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2300113 | 人纤维蛋白原 | Human fibrinogen | Lyophilized | Biological Products | Supplementary Application | 2023-06-13 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
